Imatinib
ALDRICH/CDS022173
Synonym: 4-
CAS Number: 152459-95-5
Empirical Formula (Hill Notation): C29H31N7O
Molecular Weight: 493.60
MDL Number: MFCD05662257
Linear Formula: C29H31N7O
Product Type: Chemical
| description | AldrichCPR |
| form | solid |
| InChI | 1S/C29H31N7O/c1-21-5-10-2 |
| InChI key | KTUFNOKKBVMGRW-UHFFFAOYSA |
| SMILES string | O=C(C(C=C1)=CC=C1CN2CCN(C |
| General description: | Imatinib is a benzamide derivative used as a is specific tyrosine kinase receptor inhibitor. It is designed to inhibit the breakpoint cluster region (BCR)-Abelson (ABL) fusion protein, which is caused by the Philadelphia chromosome abnormalities. Imatinib is also used as a potent apoptosis inducer and an antineoplastic agent. |
| Other Notes: | Please note that Sigma-Aldrich provides this product to early discovery researchers as part of a collection of unique chemicals. Sigma-Aldrich does not collect analytical data for this product. Buyer assumes responsibility to confirm product identity and/or purity. All sales are final. NOTWITHSTANDING ANY CONTRARY PROVISION CONTAINED IN SIGMA-ALDRICH′S STANDARD TERMS AND CONDITIONS OF SALE OR AN AGREEMENT BETWEEN SIGMA-ALDRICH AND BUYER, SIGMA-ALDRICH SELLS THIS PRODUCT "AS-IS" AND MAKES NO REPRESENTATION OR WARRANTY WHATSOEVER WITH RESPECT TO THIS PRODUCT, INCLUDING ANY (A) WARRANTY OF MERCHANTABILITY, (B) WARRANTY OF FITNESS FOR A PARTICULAR PURPOSE, OR (C) WARRANTY AGAINST INFRINGEMENT OF INTELLECTUAL PROPERTY RIGHTS OF A THIRD PARTY, WHETHER ARISING BY LAW, COURSE OF DEALING, COURSE OF PERFORMANCE, USAGE OF TRADE OR OTHERWISE. |
| Symbol | GHS08 |
| Signal word | Danger |
| Hazard statements | H341 - H351 - H360D - H362 |
| Precautionary statements | P202 - P260 - P263 - P264 - P270 - P308 + P313 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 12352200 |

